Putnam Fl Investment Management Co Stake in Intel Corp. (INTC) Trimmed by $347,714; As Chemocentryx (CCXI) Share Price Rose, Holder Bvf Has Decreased by $862,370 Its Holding

ChemoCentryx, Inc. (NASDAQ:CCXI) Logo

Putnam Fl Investment Management Co decreased its stake in Intel Corp. (INTC) by 4.73% based on its latest 2018Q4 regulatory filing with the SEC. Putnam Fl Investment Management Co sold 7,559 shares as the company’s stock rose 10.40% with the market. The institutional investor held 152,240 shares of the semiconductors company at the end of 2018Q4, valued at $7.15 million, down from 159,799 at the end of the previous reported quarter. Putnam Fl Investment Management Co who had been investing in Intel Corp. for a number of months, seems to be less bullish one the $250.49B market cap company. The stock increased 0.14% or $0.08 during the last trading session, reaching $55.68. About 11.76 million shares traded. Intel Corporation (NASDAQ:INTC) has risen 12.75% since April 9, 2018 and is uptrending. It has outperformed by 8.38% the S&P500. Some Historical INTC News: 02/04/2018 – Taiwan Semi: Intel’s Apple Pain Could Be Its Gain — Barron’s Blog; 26/04/2018 – INTEL 1Q REV. $16.1B, EST. $15.06B; 26/04/2018 – Intel Sees 2Q Rev $16.3B; 19/04/2018 – Sen. Rich Burr: Advisory: Senate Intel Committee to Hold Confirmation Hearing for Gina Haspel to Head CIA; 09/03/2018 – Intel considers bid for Broadcom: Dow Jones, citing; 29/03/2018 – TURKEY INTEL ORGANIZATION NABS 6 GULEN SUSPECTS IN BALKANS: AA; 26/04/2018 – INTEL CORP – QTRLY CLIENT COMPUTING GROUP REVENUE $8.2 BILLION, UP 3%; 27/04/2018 – Intel set to open up more than 6 percent after crushing earnings; 17/05/2018 – MOBILEYE SAYS TO START SUPPLYING AUTOMAKER WITH SELF-DRIVING SYSTEMS STARTING IN 2021; 11/05/2018 – Young Innovators from Around the World Compete at the Intel International Science and Engineering Fair

Bvf Inc decreased its stake in Chemocentryx Inc (CCXI) by 1.27% based on its latest 2018Q4 regulatory filing with the SEC. Bvf Inc sold 86,237 shares as the company’s stock rose 6.99% with the market. The hedge fund held 6.69M shares of the health care company at the end of 2018Q4, valued at $72.96 million, down from 6.77M at the end of the previous reported quarter. Bvf Inc who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $747.54 million market cap company. The stock decreased 4.24% or $0.63 during the last trading session, reaching $14.22. About 354,249 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since April 9, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/05/2018 – CHEMOCENTRYX INC – EXPECTS TO UTILIZE CASH AND INVESTMENTS BETWEEN $65 MLN AND $75 MLN FOR TWELVE MONTHS ENDING DECEMBER 31, 2018; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 09/03/2018 – ChemoCentryx Expects to Utilize Between $65M-$75M Cash and Investments in FY18; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS); 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 09/05/2018 – ChemoCentryx 1Q Loss/Shr 19c; 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END

Analysts await Intel Corporation (NASDAQ:INTC) to report earnings on April, 25. They expect $0.87 earnings per share, 0.00% or $0.00 from last year’s $0.87 per share. INTC’s profit will be $3.91B for 16.00 P/E if the $0.87 EPS becomes a reality. After $1.28 actual earnings per share reported by Intel Corporation for the previous quarter, Wall Street now forecasts -32.03% negative EPS growth.

Since October 25, 2018, it had 2 buys, and 9 sales for $893,356 activity. Rodgers Steven Ralph sold $102,050 worth of stock or 2,235 shares. SWAN ROBERT HOLMES bought $245,993 worth of Intel Corporation (NASDAQ:INTC) on Thursday, December 6. The insider McBride Kevin Thomas sold 6,500 shares worth $295,945.

Putnam Fl Investment Management Co, which manages about $1.28 billion and $920.54M US Long portfolio, upped its stake in Becton Dickinson & Co. (NYSE:BDX) by 6,026 shares to 40,986 shares, valued at $9.24 million in 2018Q4, according to the filing. It also increased its holding in Amazon.Com Inc. (NASDAQ:AMZN) by 786 shares in the quarter, for a total of 13,436 shares, and has risen its stake in Microsoft Corp. (NASDAQ:MSFT).

More notable recent Intel Corporation (NASDAQ:INTC) news were published by: Seekingalpha.com which released: “Micron And Intel: Fishy? – Seeking Alpha” on April 05, 2019, also Seekingalpha.com with their article: “Intel Vs. AMD: Battle For Market Share – Seeking Alpha” published on March 11, 2019, Nasdaq.com published: “After Hours Most Active for Mar 12, 2019 : CZR, SBUX, HPQ, ECA, AAPL, CMCSA, BAX, INTC, MSFT, COP, VER, GE – Nasdaq” on March 12, 2019. More interesting news about Intel Corporation (NASDAQ:INTC) were released by: Fool.com and their article: “Better Buy: Seagate Technology vs. Intel – Motley Fool” published on March 12, 2019 as well as Nasdaq.com‘s news article titled: “Noteworthy ETF Outflows: QQQ, MSFT, AAPL, INTC – Nasdaq” with publication date: March 13, 2019.

Investors sentiment increased to 1 in Q4 2018. Its up 0.15, from 0.85 in 2018Q3. It is positive, as 52 investors sold INTC shares while 677 reduced holdings. 141 funds opened positions while 588 raised stakes. 2.96 billion shares or 3.57% more from 2.86 billion shares in 2018Q3 were reported. 211,219 are held by Northwestern Mutual Wealth. 51,064 were accumulated by Lmr Prtn Llp. Hanson Mcclain owns 122,675 shares for 0.28% of their portfolio. Wilbanks Smith Thomas Asset Mngmt Llc invested in 0.14% or 44,639 shares. Jfs Wealth Advisors Limited Com, Pennsylvania-based fund reported 3,532 shares. Commonwealth Of Pennsylvania School Empls Retrmt reported 0.23% of its portfolio in Intel Corporation (NASDAQ:INTC). Principal Financial Gru invested in 0.36% or 7.25M shares. Peak Asset Mgmt Ltd Limited Liability Company holds 0.18% in Intel Corporation (NASDAQ:INTC) or 10,169 shares. Mu Communications Limited holds 4.04% or 117,000 shares in its portfolio. Tokio Marine Asset Co Limited owns 9,595 shares. 181,369 were accumulated by Fulton Breakefield Broenniman Ltd Limited Liability Company. Banced stated it has 19,350 shares. North owns 1.25% invested in Intel Corporation (NASDAQ:INTC) for 143,969 shares. First Manhattan, New York-based fund reported 171,887 shares. Meiji Yasuda Asset Mgmt reported 0.81% stake.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Benzinga.com which released: “Cancer Biology Clinical Research Seeking Answers at Cellular Level – Benzinga” on March 26, 2019, also Benzinga.com with their article: “10 Biggest Price Target Changes For Wednesday – Benzinga” published on March 27, 2019, Benzinga.com published: “60 Stocks Moving In Wednesday’s Mid-Day Session – Benzinga” on March 27, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Globenewswire.com and their article: “ChemoCentryx Appoints Rita Jain, M.D. to Board of Directors – GlobeNewswire” published on March 28, 2019 as well as Benzinga.com‘s news article titled: “52 Biggest Movers From Yesterday – Benzinga” with publication date: March 26, 2019.

Bvf Inc, which manages about $999.89 million and $765.19 million US Long portfolio, upped its stake in Xoma Corp Del by 266,229 shares to 1.77M shares, valued at $22.38 million in 2018Q4, according to the filing. It also increased its holding in Argenx Se by 4,060 shares in the quarter, for a total of 80,868 shares, and has risen its stake in Calithera Biosciences Inc (NASDAQ:CALA).

Since October 16, 2018, it had 0 buys, and 8 insider sales for $87.64 million activity. Cappel Markus J. sold $158,790 worth of ChemoCentryx, Inc. (NASDAQ:CCXI) on Monday, January 7. Schall Thomas J. also sold $447,092 worth of ChemoCentryx, Inc. (NASDAQ:CCXI) shares. GLAXOSMITHKLINE PLC also sold $85.85M worth of ChemoCentryx, Inc. (NASDAQ:CCXI) shares.

ChemoCentryx, Inc. (NASDAQ:CCXI) Institutional Positions Chart

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *